Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries: An Asian Network for Surveillance of Resistant Pathogens (ANSORP) study

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 3, 2012, Pages 1418-1426

  Kim, So Hyun ^a   Song, Jae Hoon ^a,b   Chung, Doo Ryeon ^b   Thamlikitkul, Visanu ^c   Yang, Yonghong ^d   Wang, Hui ^e,p   Lu, Min ^f   So, Thomas Man Kit ^g   Hsueh, Po Ren ^h   Yasin, Rohani M ⁱ   Carlos, Celia C ^j   Van Pham, Hung ^k   Lalitha, M K ^l   Shimono, Nobuyuki ^m   Perera, Jennifer ⁿ   Shibl, Atef M ^o   Baek, Jin Yang ^a   Kang, Cheol In ^b   Ko, Kwan Soo ^a,b   Peck, Kyong Ran ^b  

^a Asia Pacific Foundation for Infectious Diseases (APFID)   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c MAHIDOL UNIVERSITY   (Thailand)

^d CAPITAL MEDICAL UNIVERSITY   (China)

^e PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^f SHANGHAI JIAO TONG UNIVERSITY   (China)

^g PRINCESS MARGARET HOSPITAL   (Hong Kong)

^h NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

ⁱ INSTITUTE FOR MEDICAL RESEARCH   (Malaysia)

^j RESEARCH INSTITUTE FOR TROPICAL MEDICINE   (Philippines)

^k UNIVERSITY OF MEDICINE AND PHARMACY AT HO CHI MINH CITY   (Viet Nam)

^l MADRAS MEDICAL MISSION HOSPITAL   (India)

^m KYUSHU UNIVERSITY HOSPITAL   (Japan)

ⁿ UNIVERSITY OF COLOMBO   (Sri Lanka)

^o KING SAUD UNIVERSITY   (Saudi Arabia)

^p PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; BACTERIAL PROTEIN; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; ERMB PROTEIN; ERYTHROMYCIN; GATIFLOXACIN; LEVOFLOXACIN; MACROLIDE; MEFA PROTEIN; MOXIFLOXACIN; PENICILLIN G; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; ASIAN; BACTERIUM ISOLATE; CHINA; HONG KONG; HUMAN; IN VITRO STUDY; INDIA; MALAYSIA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHILIPPINES; PRIORITY JOURNAL; PROSPECTIVE STUDY; SOUTH KOREA; SRI LANKA; STREPTOCOCCUS PNEUMONIAE; TAIWAN; VIET NAM;

ANTI-BACTERIAL AGENTS; ASIA; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; PENICILLIN RESISTANCE; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PROSPECTIVE STUDIES; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

EID: 84863115207     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05658-11     Document Type: Article

References (26)

1. Albrich WC, Baughman W, Schmotzer B, Farley MM. 2007. Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine. Clin. Infect. Dis. 44:1569-1576. (Pubitemid 46871503)
2. Choi EH, et al. 2008. Streptococcus pneumoniae serotype 19A in children, South Korea. Emerg. Infect. Dis. 14:275-281.
3. Clinical and Laboratory Standards Institute. 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. M07-A8. Clinical and Laboratory Standards Institute, Wayne, PA.
4. Clinical and Laboratory Standards Institute. 2011. Performance standards for antimicrobial susceptibility testing; 21st informational supplement. M100-S21, vol. 31. Clinical and Laboratory Standards Institute, Wayne, PA.
5. Gertz RE, Jr, et al. 2010. Increased penicillin nonsusceptibility of nonvaccine-serotype invasive pneumococci other than serotypes 19A and 6A in post-7-valent conjugate vaccine era. J. Infect. Dis. 201:770-775.
6. Hausdorff WP, Feikin DR, Klugman KP. 2005. Epidemiological differences among pneumococcal serotypes. Lancet Infect. Dis. 5:83-93. (Pubitemid 40174779)
7. Hsieh YC, et al. 2009. National survey of invasive pneumococcal diseases in Taiwan under partial PCV7 vaccination in 2007: emergence of serotype 19A with high invasive potential. Vaccine 27:5513-5518.
8. Huang SS, et al. 2005. Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004. Pediatrics 116:e408-e413. (Pubitemid 44336655)
9. Jacobs MR, et al. 2009. Occurrence, distribution, and origins of Streptococcus pneumoniae serotype 6C, a recently recognized serotype. J. Clin. Microbiol. 47:64-72.
10. Jenkins SG, Farrell DJ. 2009. Increase in pneumococcus macrolide resistance, United States. Emerg. Infect. Dis. 15:1260-1264.
11. Johnson DM, Stilwell MG, Fritsche TR, Jones RN. 2006. Emergence of multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1999-2003). Diagn. Microbiol. Infect. Dis. 56:69-74. (Pubitemid 44279930)
12. Kim KH, et al. 2011. Nasopharyngeal pneumococcal carriage of children attending day care centers in Korea: comparison between children immunized with 7-valent pneumococcal conjugate vaccine and nonimmunized. J. Korean Med. Sci. 26:184-190.
13. Ko KS, Song JH. 2004. Evolution of erythromycin-resistant Streptococcus pneumoniae from Asian countries that contains erm(B) and mef(A) genes. J. Infect. Dis. 190:739-747.
14. Lee NY, et al. 2001. Carriage of antibiotic-resistant pneumococci among Asian children: a multinational surveillance by the Asian Network for Surveillance of Resistant Pathogens (ANSORP). Clin. Infect. Dis. 32: 1463-1469.
15. Lin TY, Shah NK, Brooks D, Garcia CS. 2010. Summary of invasive pneumococcal disease burden among children in the Asia-Pacific region. Vaccine 28:7589-7605.
16. Linares J, Ardanuy A, Pallares R, Fenoll A. 2010. Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period. Clin. Microbiol. Infect. 16:402-410.
17. Lynch JP, III, Zhanel GG. 2009. Streptococcus pneumoniae: does antimicrobial resistance matter? Semin. Respir. Crit. Care Med. 30:210-238.
18. Lynch JP, III, Zhanel GG. 2010. Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines. Curr. Opin. Pulm. Med. 16:217-225.
19. McIntosh ED, Reinert RR. 2011. Global prevailing and emerging pediatric pneumococcal serotypes. Expert Rev. Vaccines 10:109-129.
20. Moore MR, et al. 2008. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J. Infect. Dis. 197: 1016-1027. (Pubitemid 351590031)
21. Saha SK, et al. 2009. Surveillance for invasive Streptococcus pneumoniae disease among hospitalized children in Bangladesh: antimicrobial susceptibility and serotype distribution. Clin. Infect. Dis. 48(Suppl. 2):S75-S81.
22. Song JH, et al. 1999. Spread of drug-resistant Streptococcus pneumoniae in Asian countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) study. Clin. Infect. Dis. 28:1206-1211.
23. Song JH, et al. 2004. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Antimicrob. Agents Chemother. 48:2101-2107.
24. Song JH, et al. 2004. Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries: a study of the Asian Network for Surveillance of Resistant Pathogens (ANSORP). J. Antimicrob. Chemother. 53:457-463.
25. Sutcliffe J, Grebe T, Tait-Kamradt A, Wondrack L. 1996. Detection of erythromycin-resistant determinants by PCR. Antimicrob. Agents Chemother. 40:2562-2566. (Pubitemid 26367644)
26. Xue L, et al. 2010. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates that cause invasive disease among Chinese children. Clin. Infect. Dis. 50:741-744.